![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:0908K GW Pharmaceuticals PLC 16 April 2003 For Immediate Release 16 April 2003 GW Pharmaceuticals plc ("GW" or "the Company") Appointment of Non-Executive Director GW announces the appointment of Hans Schram as a non-executive director with immediate effect. Mr Schram has over 20 years experience in global pharmaceutical business development and marketing. Mr Schram is currently Chief Executive Officer of Nordic Group, a specialist pharmaceutical sales and marketing company with operations in Scandinavia, UK, Netherlands and France. Prior to this appointment he spent 18 years at Ferring Group, an international pharmaceutical company operating in over 40 countries with annual revenues of over Euro 500 million. Mr Schram was a member of Ferring's Executive Management Team and Senior Vice President, International Business Development. Mr Schram also held posts as Managing Director of several of the European affiliates and as Regional Director of the Group's operations in Asia, Central & Eastern Europe, Latin America, and Middle East. Prior to Ferring, Mr Schram was at Ciba Geigy in Switzerland and at Pierre Fabre Laboratories, the French phytomedicines company, responsible for pharmaceutical operations in Northern Europe, North America, South East Asia and Japan. Dr Geoffrey Guy, Executive Chairman, said, "Mr Schram is a seasoned pharmaceutical executive with international commercial expertise whom I am delighted to welcome to the Board. He brings to GW a wealth of experience in managing commercial relationships as well as marketing pharmaceutical products across all regions of the world." Enquiries: GW Pharmaceuticals plc (15/04/03) 020 7067 0700 Dr Geoffrey Guy, Chairman (Thereafter)01980 557000 Justin Gover, Managing Director Weber Shandwick Square Mile 020 7067 0700 Kevin Smith/Graham Herring Appendix HANS SCHRAM - LIST OF CURRENT AND FORMER DIRECTORSHIPS Former directorships held since 1 April 1998: Ferring Australia Ltd Australia Ferring Pharmaceuticals Ltd Israel Ferring Pharmaceuticals Ltd Hong Kong Ferring Yak Pum Yuhan Hoesa Korea Ferring Pharmaceuticals Ltd (Taiwan) Taiwan Ferring SA Argentina Ferring Pharmaceuticals BV Netherlands Ferring Product Development BV Netherlands Ferring Pharmaceuticals (China) Co. Ltd China Ferring Sa de CV Mexico Ferring (Proprietary) Ltd South Africa Current directorships: QPharma AB Sweden Nordic Drugs AB Sweden Nordic Pharma Ltd UK Nordic Geneesmiddelen BV Netherlands Ferring Leciva AS Czech Rep. There are no further disclosures to be made in respect of Hans Schram pursuant to paragraph (f) of Schedule 2 of the AiM Rules for companies. This information is provided by RNS The company news service from the London Stock Exchange END BOAEAELSFEADEAE
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions